Dizziness may occur, particularly if rapid weight loss leads to postural hypotension or if patients are concurrently taking antihypertensive medications that require dose adjustment
C will create a precise treatment plan tailored to your unique biochemistry and wellness goals
In addition, combining GLP-1R agonists with other peptide agonists or small-molecule therapeutics, including fibroblast growth factor 21 (FGF21), the farnesoid X receptor (FXR) agonist cilofexor with/without the acetyl coenzyme A carboxylase inhibitor firsocostat, a long-acting amylin agonist, cannabinoid receptor antagonists and sodium-glucose cotransporter 2 inhibitors (SGLT-2i), is currently being explored and may lead to additional improvements in NASH features vs GLP-1R agonists therapy alone [79,80,81,82,83]
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness